Prediction of Preeclampsia (PE) at 11-13 Week
- Conditions
- Pre-Eclampsia
- Registration Number
- NCT03554681
- Lead Sponsor
- Chiu Yee Liona Poon
- Brief Summary
This is an international multicentre prospective cohort study to validate the Bayes theorem based algorithms for the screening of pre-eclampsia (PE) in the first-trimester of pregnancy.
- Detailed Description
The investigators have previously constructed Bayes model in the first-trimester which combines maternal characteristics and medical history (Mat-CH) together with mean arterial pressure (MAP), uterine artery pulsatility index (PI), and serum placental growth factor (PlGF) with a plan to assess the predictive performance.
The reference standards will be PE defined according to the International Society for the Study of Hypertension in Pregnancy and the American College of Obstetricians and Gynecologists. The systolic blood pressure should be \>140 mm Hg and/or the diastolic blood pressure should be \>90 mmHg on at least two occasions four hours apart developing after 20 weeks' gestation in previously normotensive women and there should be proteinuria (\>300 mg in 24 hours or two readings of at \>2+ on dipstick analysis of midstream or catheter urine specimens if no 24-hour collection is available). In the absence of proteinuria, new onset of any of the following systemic findings: a) thrombocytopaenia (platelet counts \<100,000 ยตL); b) renal insufficiency (creatinine \>1.1 mg/dL or 2-fold increase in creatinine in the absence of underlying renal disease); c) abnormal liver function (ie, hepatic transaminase levels twice normal); d) pulmonary oedema; or e) cerebral or visual symptoms. Preterm-PE is PE that requires delivery before 37 weeks' gestation. If a participant fulfills the criteria for PE by one definition and not the other she will be considered to have developed PE.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 10935
- Aged โฅ 18 years
- Singleton pregnancy
- Live fetus
- Provide Informed and written consent in the official language of the country
- Unable to provide written Informed consent learning difficulties or serious mental illness or an inability to understand spoken and written the official language of the country.
- Multiple Pregnancy
- Non-viable fetus (missed spontaneous abortion or stillbirth)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The false positive and true positive frequencies for screening for PE using the Bayes theorem based methods At delivery
- Secondary Outcome Measures
Name Time Method The false positive and true positive frequencies for screening of delivery of all-Small for Gestational Age (SGA) neonates and preterm-SGA neonates (delivery before 37 weeks), with or without PE At delivery
Trial Locations
- Locations (14)
Clinical Research Institute of Fetal Medicine PMC
๐ฏ๐ตOsaka, Japan
First Affiliated Hospital of Kunming Medical University
๐จ๐ณKunming, China
Kwong Wah Hospital
๐ญ๐ฐHong Kong, Hong Kong
Toyama University Hospital
๐ฏ๐ตToyama, Toyama Prefecture, Japan
Mediscan Chennai
๐ฎ๐ณChennai, Tamil Nadu, India
KK Women's and Children's Hospital
๐ธ๐ฌSingapore, Singapore
Siriraj Hospital
๐น๐ญBangkok, Thailand
Affiliated hospitals within The Japan Society for the Study of Hypertension in Pregnancy (JSSHP)
๐ฏ๐ตTokyo, Japan
Showa University Hospital
๐ฏ๐ตTokyo, Japan
National University Hospital
๐ธ๐ฌSingapore, Singapore
Taipei Chang Gung Memorial Hospital
๐จ๐ณTaipei, Taiwan
Chulalongkorn University Bangkok
๐น๐ญBangkok, Thailand
Nanjing Drum Tower Hospital
๐จ๐ณNanjing, China
Prince of Wales Hospital
๐ญ๐ฐHong Kong, Hong Kong